Literature DB >> 6301395

Association of hypotension with hyperreninemic hypoaldosteronism in the critically ill patient.

M W Davenport, R D Zipser.   

Abstract

Paradoxical suppression of plasma aldosterone (PA) despite increased plasma renin activity (PRA) has recently been noted in some critically ill patients. To determine the prevalence of this entity and to identify possible etiologic factors, we studied 100 consecutive patients admitted to a medical intensive care unit (ICU). Twenty-two of 100 ICU patients had hyperreninemia and inappropriately reduced PA concentrations, with a PA to PRA ratio less than the 98th percentile of the control population. Comparison of clinical data of these 22 patients with the other hyperreninemic ICU patients revealed no differences in electrolyte concentrations, nutrition, medications, or survival. However, persistent hypotension was much more frequent (91% v 53%). Thus, impaired aldosterone response to hyperreninemia has a high prevalence among critically ill patients and may be related to adrenal damage from persistent hypotension.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301395

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

1.  Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Robert L Danner; Peter Q Eichacker; Anthony F Suffredini; Jing Feng; Junfeng Sun; Ellen N Behrend; Steven B Solomon; Charles Natanson
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

2.  B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS.

Authors:  Matthew W Semler; Annis M Marney; Todd W Rice; Hui Nian; Chang Yu; Arthur P Wheeler; Nancy J Brown
Journal:  Chest       Date:  2016-03-23       Impact factor: 9.410

3.  Mineralocorticoid deficiency in hemorrhagic shock.

Authors:  Nikolai S Tolstoy; Majid Aized; Morgan P McMonagle; Daniel N Holena; Jose L Pascual; Seema S Sonnad; Carrie A Sims
Journal:  J Surg Res       Date:  2012-05-25       Impact factor: 2.192

4.  Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients.

Authors:  L F Span; A R Hermus; A K Bartelink; A J Hoitsma; J S Gimbrère; A G Smals; P W Kloppenborg
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 5.  CIRMI-a new term for a concept worthy of further exploration: a narrative review.

Authors:  Gladness Dakalo Nethathe; Jeffrey Lipman; Ronald Anderson; Charles Feldman
Journal:  Ann Transl Med       Date:  2022-06

6.  Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure.

Authors:  D du Cheyron; A Lesage; C Daubin; M Ramakers; P Charbonneau
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

7.  Hyperreninemic hypoaldosteronism syndrome, plasma concentrations of interleukin-6 and outcome in critically ill patients with liver cirrhosis.

Authors:  Damien du Cheyron; Bruno Bouchet; Brigitte Cauquelin; Damien Guillotin; Michel Ramakers; Cédric Daubin; Jean-Jacques Ballet; Pierre Charbonneau
Journal:  Intensive Care Med       Date:  2007-09-29       Impact factor: 17.440

8.  The extrarenal effects of aldosterone on the distribution of extracellular fluid in conscious adrenalectomized-nephrectomized rats.

Authors:  M Ishii; M Yamakado; S Murao
Journal:  Pflugers Arch       Date:  1985-07       Impact factor: 3.657

9.  Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate.

Authors:  Nienke Molenaar; Ronald M Bijkerk; Albertus Beishuizen; Christel M Hempen; Margriet F C de Jong; Istvan Vermes; Gertjan van der Sluijs Veer; Armand R J Girbes; A B Johan Groeneveld
Journal:  Crit Care       Date:  2012-07-10       Impact factor: 9.097

10.  Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.

Authors:  Rinaldo Bellomo; Lui G Forni; Laurence W Busse; Michael T McCurdy; Kealy R Ham; David W Boldt; Johanna Hästbacka; Ashish K Khanna; Timothy E Albertson; James Tumlin; Kristine Storey; Damian Handisides; George F Tidmarsh; Lakhmir S Chawla; Marlies Ostermann
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.